Cargando…

Irritable bowel syndrome with food‐related symptoms: Future directions in the clinical management

The majority of patients with irritable bowel syndrome (IBS) experiences food‐related symptoms, which are associated with high symptom burden, reduced quality of life, increased healthcare consumption and reduced intake of certain nutrients. In this review we aimed to describe a clinically useful ap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Melchior, Chloé, Algera, Joost, Colomier, Esther, Törnblom, Hans, Simrén, Magnus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Neurogastroenterology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278572/ https://www.ncbi.nlm.nih.gov/pubmed/35727703 http://dx.doi.org/10.1002/ueg2.12265

Ejemplares similares

Irritable bowel syndrome: Factors of importance for disease‐specific quality of life
por: Melchior, Chloé, et al.
Publicado: (2022)

Association between Brachyspira and irritable bowel syndrome with diarrhoea
por: Jabbar, Karolina S, et al.
Publicado: (2021)

Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population
por: Tornkvist, Navkiran T., et al.
Publicado: (2021)

Associations between postprandial symptoms, hydrogen and methane production, and transit time in irritable bowel syndrome
por: Algera, Joost P., et al.
Publicado: (2022)

The Dietary Management of Patients with Irritable Bowel Syndrome: A Narrative Review of the Existing and Emerging Evidence
por: Algera, Joost, et al.
Publicado: (2019)

Worldwide prevalence and burden of gastroparesis‐like symptoms as defined by the United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis
por: Huang, I‐Hsuan, et al.
Publicado: (2022)

Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea
por: Colomier, Esther, et al.
Publicado: (2021)

Gastric emptying rate and relevance for symptoms
por: Törnblom, Hans
Publicado: (2023)

Disorders of gut‐brain interaction: Highly prevalent and burdensome yet under‐taught within medical education
por: Simons, Julia, et al.
Publicado: (2022)

European guidelines on functional bowel disorders with diarrhoea: United European Gastroenterology (UEG) and European Society for neurogastroenterology and motility (ESNM) statements and recommendations
por: Tornkvist, Navkiran T., et al.
Publicado: (2022)

Patient satisfaction after remotely delivered gut-directed hypnotherapy for irritable bowel syndrome during the COVID-19 era: implications for future practice
por: Noble, Hithin, et al.
Publicado: (2022)

Functional variants in the sucrase–isomaltase gene associate with increased risk of irritable bowel syndrome
por: Henström, Maria, et al.
Publicado: (2018)

Epithelial expression and function of trypsin-3 in irritable bowel syndrome
por: Rolland-Fourcade, Claire, et al.
Publicado: (2017)

Gut-focused hypnotherapy for children and adolescents with irritable bowel syndrome
por: Vasant, Dipesh H, et al.
Publicado: (2020)

A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea
por: Garsed, Klara, et al.
Publicado: (2014)

Work productivity and activity impairment in disorders of gut‐brain interaction: Data from the Rome Foundation Global Epidemiology Study
por: Frändemark, Åsa, et al.
Publicado: (2023)

A trial‐based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome
por: Weerts, Zsa Zsa R. M., et al.
Publicado: (2021)

Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: origin and effect of gut transit
por: Tooth, David, et al.
Publicado: (2014)

Irritable bowel syndrome and risk of glaucoma: An analysis of two independent population‐based cohort studies
por: McPherson, Zachary E., et al.
Publicado: (2021)

Randomised controlled trial: effects of gluten‐free diet on symptoms and the gut microenvironment in irritable bowel syndrome
por: Algera, Joost P., et al.
Publicado: (2022)

Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain
por: Akbar, A, et al.
Publicado: (2008)

Comorbidities, biomarkers and cause specific mortality in patients with irritable bowel syndrome: A phenome‐wide association study
por: Seeling, Katharina Sophie, et al.
Publicado: (2023)

Construction and validation of a questionnaire distinguishing a chronic abdominal wall pain syndrome from irritable bowel syndrome
por: van Assen, Tijmen, et al.
Publicado: (2012)

Serum L‐arginine and endogenous methylarginine concentrations predict irritable bowel syndrome in adults: A nested case‐control study
por: McEvoy, Mark A., et al.
Publicado: (2021)

Inflammatory bowel disease psychological support pilot reduces inflammatory bowel disease symptoms and improves psychological wellbeing
por: Eccles, Jessica Anne, et al.
Publicado: (2020)

Predictors of Symptom-Specific Treatment Response to Dietary Interventions in Irritable Bowel Syndrome
por: Colomier, Esther, et al.
Publicado: (2022)

The gastrointestinal tract in hunger and satiety signalling
por: Tack, Jan, et al.
Publicado: (2021)

Assessing telephone-delivered cognitive–behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial
por: Everitt, Hazel Anne, et al.
Publicado: (2019)

Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility
por: Savarino, Edoardo, et al.
Publicado: (2022)

The effectiveness of rotating versus single course antibiotics for small intestinal bacterial overgrowth
por: Richard, Nicolas, et al.
Publicado: (2021)

Interferential therapy for chronic constipation in adults: The CON‐COUR randomizedcontrolled trial
por: Vitton, Veronique, et al.
Publicado: (2023)

Type of Rectal Barostat Protocol Affects Classification of Hypersensitivity and Prediction of Symptom Severity in Irritable Bowel Syndrome
por: Josefsson, Axel, et al.
Publicado: (2022)

A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia
por: Matsueda, Kei, et al.
Publicado: (2011)

Identification of bacterial lipopeptides as key players in IBS
por: Petitfils, Camille, et al.
Publicado: (2023)

Coeliac disease enteropathy and symptoms may be aggravated by angiotensin receptor blockers in patients on a gluten‐free diet
por: O'Morain, Neil, et al.
Publicado: (2021)

Do prokinetic agents provide symptom relief through acceleration of gastric emptying? An update and revision of the existing evidence
por: Goelen, Nick, et al.
Publicado: (2023)

Close follow‐up is associated with fewer stricture formation and results in earlier detection of histological relapse in the long‐term management of eosinophilic esophagitis
por: Bon, Lorenz, et al.
Publicado: (2022)

United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia
por: Wauters, Lucas, et al.
Publicado: (2021)

Rumination syndrome: pathophysiology, diagnosis and practical management
por: Sasegbon, Ayodele, et al.
Publicado: (2022)

Global prevalence and burden of meal-related abdominal pain
por: Colomier, Esther, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_055hi7skhlbaslo7vssovs34br